小儿先天性心脏病介入治疗麻醉处理临床观察

Clin ical Observation of Anesthesia Management of Interventional Treatment for Children with Congenital Heart Disease

目的探讨小儿先天性心脏病介入治疗的麻醉处理.方法确诊动脉导管未闭(343例)、房间隔缺损(428例)、室间隔缺损(229例)择期行介入封堵术10岁以下患儿,随机分为氯胺酮复合咪达唑仑组及氯胺酮复合丙泊酚组.结果 2组患儿术中不同时点平均动脉压、心率、呼吸频率、血氧饱和度与麻醉前比较差异无统计学意义(P>0.05),组间术中不良反应、术中并发症差异无统计学意义(P>0.05),所有患儿均保留自主呼吸,顺利完成先心病介入治疗.结论氯胺酮复合咪达唑仑或氯胺酮复合丙泊酚的麻醉方法应用于先天性心脏病封堵术麻醉满意,并发症少,安全有效,麻醉苏醒快,无明显临床区别.

Objective To explore the anesthesia management of interventional treatment for congenital heart disease in children. Methods Patent ductus arteriosus （343 cases） , atrial septal defect （428 cases） , 10 years of age undergoing elective septal defect （229 cases） of the children underwent interventional therapy, were randomly divided into ketamine with midazolam group and ketamine with propofol group. Results The differences in the mean arterial pressure during operation, heart rate, respiratory rate, and oxygen saturation were not statistically significant in each group before and after anesthesia （P 〉 0.05） , and differences in adverse reaction and complications during operation were not statistically significant between the two groups （P 〉 0.05） . All patients were spontaneous breathing, and interventional treatment was completed successfully. Conclusion Ketamine with midazolam or ketamine with propofol anesthesia methods achieved satisfactory effect in the occlusion of congenital heart disease with fewer complications, safe and effective, faster recovery of anesthesia, and no clinically significant difference.